AstraZeneca gets EMA approval for Vaxzevria booster dose in adults
The EC approval follows positive CHMP recommendation in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 May 22
The EC approval follows positive CHMP recommendation in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19…
23 May 22
The FDA approval is based on data from a Phase 3 trial, conducted in two parts, Part A…
20 May 22
Abevmy marks the third oncology biosimilar to be launched by the partnership in Canada, following Ogivri (bTrastuzumab) in…
20 May 22
The CDSCO approval is based on results from the Phased 3 EMPEROR-Preserved trial which evaluated Jardiance 10mg, compared…
18 May 22
The expanded EUA is based on data, showing booster dose of Pfizer-BioNTech Covid-19 Vaccine induced superior immune response…
16 May 22
Mounjaro will be offered in six doses, 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg, together with Lilly’s auto-injector…
10 May 22
Lecanemab is indicated for mild cognitive impairment (MCI) due to AD and mild AD (collectively early AD), in…
06 May 22
The US FDA determined that the known and potential benefits of the vaccine for the prevention of Covid-19…
05 May 22
The EC approval is supported by the Phase 2 ELARA trial, which showed that Kymriah has resulted in…
04 May 22
Cabometyx is an inhibitor of the tyrosine kinases c-Met and VEGFR2, discovered and developed by genomics-based drug discovery…